Primary research

This review looks at how menopause may increase the chance of developing Alzheimer’s disease, and which biological changes might be responsible. It notes that most people with Alzheimer’s are women, that earlier menopause is linked with higher dementia risk, and that most lab research on Alzheimer’s has been done in males, so the female midlife brain has been neglected.

Hormones and brain protection

• Estradiol is described as strongly supportive of the brain: it helps nerve cells communicate, grow and repair, protects against oxidative damage, and supports how the brain uses glucose for energy.
• It also steers protein processing away from making amyloid‑β, one of the hallmark Alzheimer’s proteins.​
• In animal models, removing ovaries often worsens inflammation and memory, and estradiol can improve learning and BDNF in some cases, but in certain Alzheimer’s mouse models estradiol does not fully fix amyloid build‑up, suggesting the story is more complex than “just add oestrogen.”​
• The review also looks at FSH and LH, which rise after menopause. Blocking FSH or its receptor can improve thinking in Alzheimer’s‑model mice, and LH changes can alter memory and BDNF, with the effects depending on dose and context.​

Inflammation, white matter and blood vessels

• With estradiol loss, the brain tends to shift toward a more inflammatory state, with more activated support cells and faster loss of connections between neurons.
• Women with Alzheimer’s show more severe damage in white matter than men, including changes in myelin proteins that may make the insulating coating of nerve fibres more prone to breakdown.​
• The review also notes that estrogen affects the blood–brain barrier in specific regions, implying that menopause changes how well the brain’s blood vessels protect and feed brain tissue.​

Brain energy and midlife vulnerability

• A decline in brain glucose use and changes in insulin signalling are highlighted as early features of Alzheimer’s, and estradiol is described as helping the brain use glucose efficiently.​
• Losing estradiol around midlife is therefore presented as a shift that can leave the brain in a more energy‑stressed state just when age‑related risks are rising.​

Overall, the paper portrays menopause as a critical transition where changes in estradiol, FSH and LH, inflammation, blood vessels, white matter integrity and brain fuel use all interact with genetic risk (such as APOE) to shape long‑term Alzheimer’s susceptibility.

Source: Brain Research